In the following you get an overview about the latest press reports:
|
| FDA publish DMF Number for synthetic CBD
(November, 2008) |
Drug Master File (DMF) No 22103 for Synthetic Cannabidiol became active in the United States November 2008.
In a joint venture between THC Pharm and STI Pharmaceuticals Ltd the
DMF submission to the FDA is intended to open new opportunities for
researchers in the US and Europe wishing to advance into human clinical
trials.
CBD is currently under investigation for its medical potential in a range
of indications such as Parkinson's disease, Diabetes and Cancer. |
| |
| THC Pharm welcomes
first license for cannabis based medication for multiple sklerosis
(May, 3rd, 2005) |
|
| |
| THC Pharm obtains patent for
improved Dronabinol production process (March, 10th,2005) |
| Production of synthetic cannabinoids planned for 2005 |
|
| |
| THC Pharm launches its new
website (Oct, 2nd, 2003) |
|
| |
| THC Pharm aims to obtain a license for a Cannabis
medication (June,30th, 2003) |
| Five years Dronabinol from THC Pharm – price reduction from 1st
of July |
|
| |
| THC Pharm sees growing market for cannabis as
medicine (May, 30th, 2002) |
|
| |
| Revolution in pain therapy by possibility of inhalation (March, 13th, 2001) |
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
